229 related articles for article (PubMed ID: 15161669)
61. Risk for smoking-related cancer among relatives of lung cancer patients.
Etzel CJ; Amos CI; Spitz MR
Cancer Res; 2003 Dec; 63(23):8531-5. PubMed ID: 14679021
[TBL] [Abstract][Full Text] [Related]
62. A population-based study on serious inpatient bacterial infections in patients with chronic lymphocytic leukemia and their impact on survival.
Steingrímsson V; Gíslason GK; Aspelund T; Turesson I; Björkholm M; Landgren O; Kristinsson SY
Eur J Haematol; 2020 Nov; 105(5):547-554. PubMed ID: 32575150
[TBL] [Abstract][Full Text] [Related]
63. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.
Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES
Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478
[TBL] [Abstract][Full Text] [Related]
64. Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.
Parikh SA; Habermann TM; Chaffee KG; Call TG; Ding W; Leis JF; Macon WR; Schwager SM; Ristow KM; Porrata LF; Kay NE; Slager SL; Shanafelt TD
Am J Hematol; 2015 Apr; 90(4):334-8. PubMed ID: 25581025
[TBL] [Abstract][Full Text] [Related]
65. Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.
Awan H; Jønsson V; Johannesen TB; Ly B; Tjønnfjord GE
Transl Oncogenomics; 2010 Mar; 4():1-9. PubMed ID: 21566766
[TBL] [Abstract][Full Text] [Related]
66. Familial chronic lymphocytic leukemia.
Sellick GS; Catovsky D; Houlston RS
Semin Oncol; 2006 Apr; 33(2):195-201. PubMed ID: 16616066
[TBL] [Abstract][Full Text] [Related]
67. VH gene usage by family members affected with chronic lymphocytic leukaemia.
Pritsch O; Troussard X; Magnac C; Mauro FR; Davi F; Payelle-Brogard B; Dumas G; Pulik M; Clerget F; Mandelli F; Chiorazzi N; Schroeder HW; Leporrier M; Dighiero G
Br J Haematol; 1999 Dec; 107(3):616-24. PubMed ID: 10583268
[TBL] [Abstract][Full Text] [Related]
68. Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers.
Chatterjee N; Hartge P; Cerhan JR; Cozen W; Davis S; Ishibe N; Colt J; Goldin L; Severson RK
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1415-21. PubMed ID: 15342441
[TBL] [Abstract][Full Text] [Related]
69. Clonal lymphocytes in persons without known chronic lymphocytic leukemia (CLL): implications of recent findings in family members of CLL patients.
Rawstron A; Hillmen P; Houlston R
Semin Hematol; 2004 Jul; 41(3):192-200. PubMed ID: 15269879
[TBL] [Abstract][Full Text] [Related]
70. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia.
Sellick GS; Rudd M; Eve P; Allinson R; Matutes E; Catovsky D; Houlston RS
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1065-7. PubMed ID: 15184265
[TBL] [Abstract][Full Text] [Related]
71. Population-based, multigenerational family clustering study of obsessive-compulsive disorder.
Mataix-Cols D; Boman M; Monzani B; Rück C; Serlachius E; Långström N; Lichtenstein P
JAMA Psychiatry; 2013 Jul; 70(7):709-17. PubMed ID: 23699935
[TBL] [Abstract][Full Text] [Related]
72. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
Shirai T
Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
[TBL] [Abstract][Full Text] [Related]
73. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
74. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
[TBL] [Abstract][Full Text] [Related]
75. Association of various risk factors with chronic lymphocytic leukemia and its cytogenetic characteristics.
Karakosta M; Delicha EM; Kouraklis G; Manola KN
Arch Environ Occup Health; 2016 Nov; 71(6):317-329. PubMed ID: 26566973
[TBL] [Abstract][Full Text] [Related]
76. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
77. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway.
Hemminki K; Tretli S; Sundquist J; Johannesen TB; Granström C
Lancet Oncol; 2009 May; 10(5):481-8. PubMed ID: 19356978
[TBL] [Abstract][Full Text] [Related]
78. Familial Risk in Patients With Carcinoma of Unknown Primary.
Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
[TBL] [Abstract][Full Text] [Related]
79. Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia.
Cuttner J
Cancer Invest; 1992; 10(2):103-9. PubMed ID: 1551021
[TBL] [Abstract][Full Text] [Related]
80. A genetic study of Hodgkin's lymphoma: an estimate of heritability and anticipation based on the familial cancer database in Sweden.
Shugart YY; Hemminki K; Vaittinen P; Kingman A; Dong C
Hum Genet; 2000 May; 106(5):553-6. PubMed ID: 10914686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
